Overall, we suggested that tumor angiogenesis in renal cancer cell could be inhibited by SLC39A1 through downregulating ANGPTL4, and inactivated PPAR signal pathway was the underlying mechanism. This evidence concerns the gene SLC39A1 and renal carcinoma.